Exact Mass: 233.08
Exact Mass Matches: 233.08
Found 115 metabolites which its exact mass value is equals to given mass value 233.08
,
within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error
0.001 dalton.
1-Hydroxy-2-(N-acetylcysteinyl)-3-butene
4-(3-Pyridin-2-yl-[1,2,4]oxadiazol-5-yl)-butyric acid
(2R)-2-Acetamido-6-hydroxy-2-(sulfanylmethyl)hex-3-enoic acid
4,5Dimethyl-3-(2-oxo-2-phenyl-ethyl)-thiazole
5-Acetoacetamino benzimidazolone
CONFIDENCE standard compound; INTERNAL_ID 387; DATASET 20200303_ENTACT_RP_MIX505; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 2379; ORIGINAL_PRECURSOR_SCAN_NO 2376 CONFIDENCE standard compound; INTERNAL_ID 387; DATASET 20200303_ENTACT_RP_MIX505; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 2374; ORIGINAL_PRECURSOR_SCAN_NO 2372 CONFIDENCE standard compound; INTERNAL_ID 387; DATASET 20200303_ENTACT_RP_MIX505; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 2378; ORIGINAL_PRECURSOR_SCAN_NO 2375 CONFIDENCE standard compound; INTERNAL_ID 387; DATASET 20200303_ENTACT_RP_MIX505; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 2368; ORIGINAL_PRECURSOR_SCAN_NO 2365 CONFIDENCE standard compound; INTERNAL_ID 387; DATASET 20200303_ENTACT_RP_MIX505; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 2441; ORIGINAL_PRECURSOR_SCAN_NO 2438 CONFIDENCE standard compound; INTERNAL_ID 387; DATASET 20200303_ENTACT_RP_MIX505; DATA_PROCESSING MERGING RMBmix ver. 0.2.7; DATA_PROCESSING PRESCREENING Shinyscreen ver. 0.8.0; ORIGINAL_ACQUISITION_NO 2381; ORIGINAL_PRECURSOR_SCAN_NO 2378
6-Methyl-2-phenyl-1,3,6,2-dioxazaborocane-4,8-dione
2-PYRIMIDINAMINE, 4-CHLORO-6-METHYL-5-(PHENYLMETHYL)-
2-ethyl-6-fluoro-3-methylquinoline-4-carboxylic acid
Mofegiline hydrochloride
D002491 - Central Nervous System Agents > D018726 - Anti-Dyskinesia Agents > D000978 - Antiparkinson Agents D004791 - Enzyme Inhibitors > D008996 - Monoamine Oxidase Inhibitors C471 - Enzyme Inhibitor > C667 - Monoamine Oxidase Inhibitor
1H-Isoindole-1,3(2H)-dione,2-[(trimethylsilyl)methyl]-
3,5-DIMETHOXY-4-HYDROXYPHENETHYLAMINEHYDROCHLORIDE
4-(1-HYDROXY-2-(METHYLAMINO)ETHYL)-2-METHOXYPHENOL HYDROCHLORIDE
3-(TERT-BUTOXYCARBONYL)THIAZOLIDINE-2-CARBOXYLIC ACID
1H-1,2,4-Triazole-1-aceticacid,4,5-dihydro-4-(4-methylphenyl)-5-oxo-
tert-butyl (2S)-2-(2-chloroacetyl)azetidine-1-carboxylate
Ethyl2,5-dihydro-5-oxo-1-phenyl-1H-1,2,4-triazole-3-carboxylate
BU 224 hydrochloride,2-(4,5-Dihydroimidazol-2-yl)quinolinehydrochloride
2-(7-fluoro-1,2,3,4-tetrahydrocyclopenta[b]indol-3-yl)acetic acid
2-[5-methyl-2-(4-methylphenyl)-1,3-thiazol-4-yl]ethanol
4-(3-pyridin-3-yl-1,2,4-oxadiazol-5-yl)butanoic acid
2-(tert-butoxycarbonylamino)-3-Methoxy-3-oxopropanoic acid
alpha-(Aminomethyl)-2,5-dimethoxybenzyl alcohol hydrochloride
1-(4-Methoxy-benzyl)-1H-[1,2,3]triazole-4-carboxylic acid
6-Fluoro-2,3,4,9-tetrahydro-1H-carbazole-3-carboxylic acid
methyl (E)-3-(furan-2-yl)-2-(1,2,4-triazol-1-ylmethyl)prop-2-enoate
Benzenemethanamine,N-(3-chloropropyl)-N-methyl-, hydrochloride (1:1)
3-(1-methylsulfonylpiperidin-4-yl)prop-2-enoic acid
Methyl (1S,5R)-8-methyl-3-oxo-8-azabicyclo[3.2.1]octane-2-carboxylate hydrochloride (1:1)
(2S)-2-[3-FLUORO-4-(TRIFLUOROMETHYL)PHENYL]PYRROLIDINE
(2S)-2-[5-FLUORO-2-(TRIFLUOROMETHYL)PHENYL]PYRROLIDINE
(S)-Pyrrolidin-3-yl-(1-thiazol-2-yl-ethyl)-aMine hydrochloride
(R)-Pyrrolidin-3-yl-(1-thiazol-2-yl-ethyl)-aMine hydrochloride
Methyl 2-(5-hydroxy-1-(pyridin-2-yl)-1H-pyrazol-3-yl)acetate
5-Amino-1-(4-methoxyphenyl)-1H-pyrazole-4-carboxylic acid
N-(6-chloro-2-phenyl-4-pyrimidinyl)-N,N-dimethylamine
2,1,3-Benzoxadiazol-5-yl(morpholin-4-yl)methanone
CX 717 is a positive allosteric modulator of AMPA receptor. Antidepressant-like effect. CX 717 can be used for the research of adult attention deficit hyperactivity disorder (ADHD)[1][2].
Butanamide, N-(2,3-dihydro-2-oxo-1H-benzimidazol-5-yl)-3-oxo-
(2S)-2-[[(2S)-2-azaniumyl-2-carboxylatoethyl]azaniumyl]pentanedioate
(2R)-2-Acetamido-6-hydroxy-2-(sulfanylmethyl)hex-3-enoic acid
(2S)-2-[2-(2-azaniumylethylamino)-2-oxoethyl]-2-hydroxybutanedioate
(4Z,7Z)-deca-4,7-dien-1-yl sulfate
An organosulfate oxoanion that is the conjugate base of (4Z,7Z)-deca-4,7-dien-1-yl hydrogen sulfate. It has been isolated from Daphnia pulex and has been shown to cause morphological changes in the green alga Scenedesmus gutwinskii.